Early assessment of antibodies decline in Chagas patients following treatment using a serological multiplex immunoassay
Abstract Chagas disease following infection with Trypanosoma cruzi is a major public health issue, with the disease spreading beyond endemic regions and becoming more global due to the migration of infected individuals. The currently available anti-parasitic drugs, nifurtimox and benznidazole, remai...
Saved in:
| Main Authors: | Ursula Saade, Jasper de Boer, Ivan Scandale, Jaime Altcheh, Hans Pottel, Eric Chatelain, Maan Zrein |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-12-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-024-54910-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Longitudinal follow up of serological response in children treated for Chagas disease.
by: Guillermo Moscatelli, et al.
Published: (2019-08-01) -
Deep serological profiling of the Trypanosoma cruzi TSSA antigen reveals different epitopes and modes of recognition by Chagas disease patients.
by: Guadalupe Romer, et al.
Published: (2023-08-01) -
Multicenter performance comparison of the hepatitis C antibody serology assay on the new Atellica integrated chemistry and immunoassay analyzer
by: Joe M. El-Khoury, et al.
Published: (2025-06-01) -
Assessment of serological tests for antibodies to different antigens of the SARS-CoV-2 virus: comparison of six immunoassays
by: V. V. Belyakova, et al.
Published: (2021-12-01) -
Calibrating multiplex serology for Helicobacter pylori
by: Emmanuelle A. Dankwa, et al.
Published: (2025-08-01)